In December, High Impact Medicine was launched to bring together medics to engage with opportunities to have a wide-reaching positive impact alongside and learning from clinical practice.

We’re excited to announce that we’re launching a German chapter, High Impact Medicine Germany.

We’re creating a space for EAs that are medical students or professionals, as well as for medics interested in doing good. First, we aim to focus on the national community and will be establishing local groups as time progresses.

To foster the community, we’re organising regular online events, as well as running High Impact Medicine’s 8 week fellowship. Also, we’re planning an in-person retreat to bring everyone together.

If you’re interested in staying up to date, join our newsletter!
If you want to get involved, fill out this form

If you have any questions or comments, please get in touch with Erik Jentzen and Pauline Scheuber at highimpactmedicine.germany@gmail.com.

Comments


No comments on this post yet.
Be the first to respond.
Curated and popular this week
trammell
 ·  · 25m read
 · 
Introduction When a system is made safer, its users may be willing to offset at least some of the safety improvement by using it more dangerously. A seminal example is that, according to Peltzman (1975), drivers largely compensated for improvements in car safety at the time by driving more dangerously. The phenomenon in general is therefore sometimes known as the “Peltzman Effect”, though it is more often known as “risk compensation”.[1] One domain in which risk compensation has been studied relatively carefully is NASCAR (Sobel and Nesbit, 2007; Pope and Tollison, 2010), where, apparently, the evidence for a large compensation effect is especially strong.[2] In principle, more dangerous usage can partially, fully, or more than fully offset the extent to which the system has been made safer holding usage fixed. Making a system safer thus has an ambiguous effect on the probability of an accident, after its users change their behavior. There’s no reason why risk compensation shouldn’t apply in the existential risk domain, and we arguably have examples in which it has. For example, reinforcement learning from human feedback (RLHF) makes AI more reliable, all else equal; so it may be making some AI labs comfortable releasing more capable, and so maybe more dangerous, models than they would release otherwise.[3] Yet risk compensation per se appears to have gotten relatively little formal, public attention in the existential risk community so far. There has been informal discussion of the issue: e.g. risk compensation in the AI risk domain is discussed by Guest et al. (2023), who call it “the dangerous valley problem”. There is also a cluster of papers and works in progress by Robert Trager, Allan Dafoe, Nick Emery-Xu, Mckay Jensen, and others, including these two and some not yet public but largely summarized here, exploring the issue formally in models with multiple competing firms. In a sense what they do goes well beyond this post, but as far as I’m aware none of t
LewisBollard
 ·  · 6m read
 · 
> Despite the setbacks, I'm hopeful about the technology's future ---------------------------------------- It wasn’t meant to go like this. Alternative protein startups that were once soaring are now struggling. Impact investors who were once everywhere are now absent. Banks that confidently predicted 31% annual growth (UBS) and a 2030 global market worth $88-263B (Credit Suisse) have quietly taken down their predictions. This sucks. For many founders and staff this wasn’t just a job, but a calling — an opportunity to work toward a world free of factory farming. For many investors, it wasn’t just an investment, but a bet on a better future. It’s easy to feel frustrated, disillusioned, and even hopeless. It’s also wrong. There’s still plenty of hope for alternative proteins — just on a longer timeline than the unrealistic ones that were once touted. Here are three trends I’m particularly excited about. Better products People are eating less plant-based meat for many reasons, but the simplest one may just be that they don’t like how they taste. “Taste/texture” was the top reason chosen by Brits for reducing their plant-based meat consumption in a recent survey by Bryant Research. US consumers most disliked the “consistency and texture” of plant-based foods in a survey of shoppers at retailer Kroger.  They’ve got a point. In 2018-21, every food giant, meat company, and two-person startup rushed new products to market with minimal product testing. Indeed, the meat companies’ plant-based offerings were bad enough to inspire conspiracy theories that this was a case of the car companies buying up the streetcars.  Consumers noticed. The Bryant Research survey found that two thirds of Brits agreed with the statement “some plant based meat products or brands taste much worse than others.” In a 2021 taste test, 100 consumers rated all five brands of plant-based nuggets as much worse than chicken-based nuggets on taste, texture, and “overall liking.” One silver lining
 ·  · 1m read
 · 
Recent opportunities in Career choice
34
cescorza
· · 2m read